相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Complement is an essential component of the immune response to adeno-associated virus vectors
Anne K. Zaiss et al.
JOURNAL OF VIROLOGY (2008)
Prolonged susceptibility to antibody-mediated neutralization for adeno-associated vectors targeted to the liver
Samuel L. Murphy et al.
MOLECULAR THERAPY (2008)
Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance
Baodong Sun et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Vaccines based on novel adeno-associated virus vectors elicit aberrant CD8+ T-Cell responses in mice
Hanping Lin et al.
JOURNAL OF VIROLOGY (2007)
AAV as an immunogen
Luk H. Vandenberghe et al.
CURRENT GENE THERAPY (2007)
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
Federico Mingozzi et al.
BLOOD (2007)
Immune responses to AAV in clinical trials
Federico Mingozzi et al.
CURRENT GENE THERAPY (2007)
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer
Ou Cao et al.
BLOOD (2007)
Toll-like receptors impact on safety and efficacy of gene transfer vectors
Scott E. Hensley et al.
MOLECULAR THERAPY (2007)
Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo
Chengwen Li et al.
JOURNAL OF VIROLOGY (2007)
Muscle as a target for supplementary factor IX gene transfer
Brad E. Hoffman et al.
HUMAN GENE THERAPY (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humans
Federico Mingozzi et al.
NATURE MEDICINE (2007)
Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
Amit C. Nathwani et al.
BLOOD (2007)
Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines
Outi Rautsi et al.
JOURNAL OF GENE MEDICINE (2007)
AAV vectors encoding malarial antigens stimulate antigen-specific immunity but do not protect from parasite infection
Grant J. Logan et al.
VACCINE (2007)
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy
Zejing Wang et al.
HUMAN GENE THERAPY (2007)
T-cell regulation: with complements from innate immunity
Claudia Kemper et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells
Ke-Qin Xin et al.
JOURNAL OF VIROLOGY (2006)
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy
Haiyan Jiang et al.
BLOOD (2006)
Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered (vol 103, pg 12993, 2006)
Maria P. Limberis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9
Bassel Akache et al.
JOURNAL OF VIROLOGY (2006)
Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B
Haiyan Jiang et al.
MOLECULAR THERAPY (2006)
Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered
Maria P. Limberis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Luk H. Vandenberghe et al.
NATURE MEDICINE (2006)
Gene targeting in vivo by adeno-associated virus vectors
Daniel G. Miller et al.
NATURE BIOTECHNOLOGY (2006)
Intracellular pattern recognition receptors in the host response
Etienne Meylan et al.
NATURE (2006)
Long-term correction of ammonia metabolism and prolonged survival in ornithine transcarbamylase-deficient mice following liver-directed treatment with adeno-associated viral vectors
David Moscioni et al.
MOLECULAR THERAPY (2006)
Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs
HY Jiang et al.
BLOOD (2006)
Functional significance of factor H binding to Neisseria meningitidis
Muriel C. Schneider et al.
JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptors and RNA helicases: Two parallel ways to trigger antiviral responses
Etienne Meylan et al.
MOLECULAR CELL (2006)
Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle
Alex Mas et al.
DIABETES (2006)
Loss of Siglec expression on T lymphocytes during human evolution
Dzung H. Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors
CL Halbert et al.
HUMAN GENE THERAPY (2006)
APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons
H Chen et al.
CURRENT BIOLOGY (2006)
Human immunoglobulin inhibits liver transduction by AAV vectors at low AAV2 neutralizing titers in SCID mice
CD Scallan et al.
BLOOD (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Complement amplification revisited
HU Lutz et al.
MOLECULAR IMMUNOLOGY (2006)
Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization
MA Lochrie et al.
JOURNAL OF VIROLOGY (2006)
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates
GP Gao et al.
MOLECULAR THERAPY (2006)
High levels of persistent expression of (A-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses
BP De et al.
MOLECULAR THERAPY (2006)
Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice
C. Riviere et al.
GENE THERAPY (2006)
Identification of mouse AAV capsid-specific CD8+ T cell epitopes
DE Sabatino et al.
MOLECULAR THERAPY (2005)
Novel caprine adeno-associated virus (AAV) capsid (AAV-Go.1) is closely related to the primate AAV-5 and has unique tropism and neutralization properties
AE Arbetman et al.
JOURNAL OF VIROLOGY (2005)
Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness
GM Acland et al.
MOLECULAR THERAPY (2005)
Precise hit: Adeno-associated virus in gene targeting
A Vasileva et al.
NATURE REVIEWS MICROBIOLOGY (2005)
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors
Y Lai et al.
NATURE BIOTECHNOLOGY (2005)
Evasion of immune responses to introduced human acid α-glucosidase by liver-restricted expression in glycogen storage disease type II
LM Franco et al.
MOLECULAR THERAPY (2005)
Major role of local immune responses in antibody formation to factor IX in AAV gene transfer
L Wang et al.
GENE THERAPY (2005)
Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques
PR Johnson et al.
JOURNAL OF VIROLOGY (2005)
Erythropoietin gene therapy leads to autoimmune anemia in macaques
GP Gao et al.
BLOOD (2004)
Autoimmune anemia in macaques following erythropoietin gene therapy
P Chenuaud et al.
BLOOD (2004)
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors
CE Thomas et al.
JOURNAL OF VIROLOGY (2004)
AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of α-galactosidase A and the induction of immune tolerance in Fabry mice
RJ Ziegler et al.
MOLECULAR THERAPY (2004)
The interface between innate and adaptive immunity
K Hoebe et al.
NATURE IMMUNOLOGY (2004)
The complement system in regulation of adaptive immunity
MC Carroll
NATURE IMMUNOLOGY (2004)
Induction of antigen-specific CD4+T-cell anergy and deletion by in vivo viral gene transfer
E Dobrzynski et al.
BLOOD (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain
CS Peden et al.
JOURNAL OF VIROLOGY (2004)
Retroviral restriction by APOBEC proteins
RS Harris et al.
NATURE REVIEWS IMMUNOLOGY (2004)
The complement system in B cell regulation
MC Carroll
MOLECULAR IMMUNOLOGY (2004)
Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies
NA Huttner et al.
GENE THERAPY (2003)
Identification of PDGFR as a receptor for AAV-5 transduction
G Di Pasquale et al.
NATURE MEDICINE (2003)
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer
F Mingozzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
GP Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques
AC Nathwani et al.
BLOOD (2002)
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy
RW Herzog et al.
HUMAN GENE THERAPY (2002)
Differential activation of innate immune responses by adenovirus and adeno-associated virus vectors
AK Zaiss et al.
JOURNAL OF VIROLOGY (2002)
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
JD Mount et al.
BLOOD (2002)
Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors
ZY Yan et al.
JOURNAL OF VIROLOGY (2002)
Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo
H Nakai et al.
JOURNAL OF VIROLOGY (2001)
A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus
KQ Xin et al.
HUMAN GENE THERAPY (2001)
Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies
L Cordier et al.
HUMAN GENE THERAPY (2001)
Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors
A Sarukhan et al.
JOURNAL OF VIROLOGY (2001)
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
DS Duan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle
N Chirmule et al.
JOURNAL OF VIROLOGY (2000)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
分享论文
